5-Amino-2-methylisonicotinic acid

Catalog No.: 
ACBNZP128
CAS No.: 
88482-17-1
Molecular Formula: 
C7H8N2O2
Molecular Weight: 
152.15
5-Amino-2-methylisonicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$59.00In stockInquiry
250mg97%$117.00In stockInquiry
1g97%$326.00In stockInquiry
5g97%$1302.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-2-methylisonicotinic acid
IUPAC Name5-amino-2-methylisonicotinic acid
MDL No.MFCD15143307
Molecular FormulaC7H8N2O2
Molecular Weight152.15
SMILESCC1=NC=C(N)C(=C1)C(O)=O
InChI KeyBXOBZGPEZABVEA-UHFFFAOYSA-N
Synonym5-Amino-2-methylisonicotinic acid | AMY10235 | 4-PYRIDINECARBOXYLIC ACID, 5-AMINO-2-METHYL- | FT-0702101 | C76925 | ZB0105 | 5-Amino-2-methylisonicotinicacid | SCHEMBL7654741 | A842619 | MFCD15143307 | CS-0053917 | 5-Amino-2-methylpyridine-4-carboxylic ac
CAS No.88482-17-1
PubChem CID22460861

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBNZP128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWNA748 route compound structure diagram
    ACIWNA748860369-48-8In Stock
  2. Then
  3. ACBNZP128 route product structure diagram
    ACBNZP12888482-17-1In Stock
Inquiry

2. ACBNZP128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMIAZ806 route compound structure diagram
    ACMIAZ806342618-24-0In Stock
  2. Then
  3. ACBNZP128 route product structure diagram
    ACBNZP12888482-17-1In Stock
Inquiry

3. ACBNZP128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQTTC016 route compound structure diagram
    ACQTTC01652393-72-3In Stock
  2. Then
  3. ACBNZP128 route product structure diagram
    ACBNZP12888482-17-1In Stock
Inquiry

Comments (0)